"dental crowns , materials , accessories " 이스라엘 - 히브리어 - Ministry of Health

"dental crowns , materials , accessories "

"דנקר דנטל שיווק בע""מ." - רופא - "כתרים , חומרים לכתרים ועזרים"

EarlySense Central Display Station (CDS) (also known as EverOn Central Display Station) 이스라엘 - 히브리어 - Ministry of Health

earlysense central display station (cds) (also known as everon central display station)

earlysense - אחות - המערכת משמשת כתחנת תצוגה מרכזית של נתונים (מדידות והתרעות של דופק, נשימה, תנועה, שינויי תנוחה) הנאספים ממכשירי אבר-און הממוקמים במיטות שונות בו-זמנית. מיועד לשימוש במחלקות בתי חולים, בתי אבות וכדומה.

רווהכול 이스라엘 - 히브리어 - Ministry of Health

רווהכול

megapharm ltd - borneol; camphene; cineole; menthol; menthone; pinene; pinene - קפסולות - menthol 32 mg; menthone 6 mg; pinene 3.4 mg; borneol 5 mg; camphene 5 mg; cineole 2 mg; pinene 13.6 mg - an adjuvant in the treatment of gall-bladder stones and liver diseases.

רווהטינקס 이스라엘 - 히브리어 - Ministry of Health

רווהטינקס

megapharm ltd - anethole; borneol; camphene; cineole; fenchone; pinene alfa; pinene beta - קפסולות - camphene 15 mg; cineole 3 mg; fenchone 4 mg; borneol 10 mg; anethole 4 mg; pinene beta 6.2 mg; pinene alfa 24.8 mg - urinary concrement solvents - as an adjuvant in infections of kidenys and urinary tract.

רווהטינקס 이스라엘 - 히브리어 - Ministry of Health

רווהטינקס

megapharm ltd - anethole; borneol; camphene; cineole; fenchone; pinene alfa; pinene beta - קפסולות - camphene 15 mg; cineole 3 mg; fenchone 4 mg; borneol 10 mg; anethole 4 mg; pinene beta 6.2 mg; pinene alfa 24.8 mg

רווהכול 이스라엘 - 히브리어 - Ministry of Health

רווהכול

megapharm ltd - borneol; camphene; cineole; menthol; menthone; pinene; pinene - קפסולות - menthol 32 mg; menthone 6 mg; pinene 3.4 mg; borneol 5 mg; camphene 5 mg; cineole 2 mg; pinene 13.6 mg

ארומזין 이스라엘 - 히브리어 - Ministry of Health

ארומזין

pfizer pfe pharmaceuticals israel ltd - exemestane - טבליות מצופות - exemestane 25 mg - exemestane - exemestane - aromasin is indicated for the treatment of advanced breast cancer (abc) in women with natural or induced postmenopausal status whose disease has progressed following anti-oestrogen therapy alone. aromasin is also indicated for the treatment of postmenopausal women with abc whose disease has progressed following multiple hormonal therapies. aromasin is indicated for the adjuvant treatment of postmenopausal women with oestrogen receptor positive invasive early breas cancer following 2-3 years of initial adjuvant tamoxifen therapy.